« Previous
Next »
Phytomedicine
Volume 16, Issue 1
, Pages 56-64
, January 2009
A pharmaceutical preparation of Salvia miltiorrhiza protects cardiac myocytes from tumor necrosis factor-induced apoptosis and reduces angiotensin II-stimulated collagen synthesis in fibroblasts
References
- . Anti-tumour necrosis factor-α therapy in heart failure: future directions. Basic Clin. Pharmacol. Toxicol. 2006;99:391–397
- . Salvianolic acid B attenuates VCAM-1 and ICAM-1 expression in TNF-alpha-treated human aortic endothelial cells. J. Cell Biochem. 2001;82:512–521
- . Herbal remedies. N. Engl. J. Med. 2002;347:2046–2056
- . Study on the mechanisms of an extract of Salvia miltiorrhiza on the regulation of permeability of endothelial cells exposed to tumour necrosis factor-alpha. J. Pharm. Pharmacol. 2007;59:1027–1033
- . Aqueous extract of Salvia miltiorrhiza regulates adhesion molecule expression of TNF-α-induced endothelial cells by blocking activation of nuclear factor κB. J. Cardiovasc. Pharmacol. 2005;45:516–524
- . Tanshinone IIA protects cardiac myocytes against oxidative stress-triggered damage and apoptosis. Eur. J. Pharmacol. 2007;568:213–221
- . Inhibition of serum deprivation-induced PC12 cell apoptosis by tanshinone IIA. Acta Pharmacol. Sin. 2001;22:459–462
- . Inhibition of shear-induced platelet aggregation in rat by tetramethylpyrazine and salvianolic acid B. Clin. Hemorheol. Microcirc. 2004;31:97–103
- . Protective effects of tanshinone IIA on human umbilical vein endothelial cell injured by hydrogen peroxide and its mechanism. J. Ethnopharmacol. 2006;108:217–222
- . Effects of a Chinese herb preparation on vascular cells in culture: mechanisms of cardiovascular protection. Clin. Exp. Pharma. Physiol. 2005;32:571–578
- . Effects of four medicinal herbs on human vascular endothelial cells in culture. Int. J. Cardiol. 2007;8:(online publication)
- . A preparation of herbal medicine Salvia miltiorrhiza reduces expression of intracellular adhesion molecule-1 and development of atherosclerosis in ApoE-deficient mice. J. Cardiovasc. Pharmacol. 2008;51:38–44
- . Programmed cell death in cardiac myocytes: strategies to maximize post-ischemic salvage. Heart Fail Rev. 2008;13:193–209
- . Tanshinone IIA inhibits low density lipoprotein oxidation in vitro. Free Radical Res. 2000;33:305–312
- . Inhibitory effect of the water-soluble extract of Salvia miltiorrhiza on neutrophil–endothelial adhesion. Jpn. J. Pharmacol. 2002;90:276–280
- . Relaxin modulates cardiac fibroblast proliferation, differentiation, and collagen production and reverses cardiac fibrosis in vivo. Endocrinology. 2004;145:4125–4133
- . Effect of salvianolic acids from Radix Salviae miltiorrhizae on regional cerebral blood flow and platelet aggregation in rats. Phytomedicine. 2002;9:405–409
- . Myocyte apoptosis in heart failure. Cardiovasc. Res. 2005;67:21–29
- . Salvionolate inhibits proliferation and endothelin release in cultures rat mesangial cells. Acta Pharmacol. Sin. 2001;22:629–633
- . Protective effects of sodium tanshinone IIA sulphonate against adriamycin-induced lipid peroxidation in mice hearts in vivo and in vitro. Pharmacol. Res. 1999;40:487–491
- . Protocatechuic aldehyde suppresses TNF-alpha-induced ICAM-1 and VCAM-1 expression in human umbilical vein endothelial cells. Eur. J. Pharmacol. 2005;513:1–8
PII: S0944-7113(08)00172-4
doi: 10.1016/j.phymed.2008.09.008
© 2008 Elsevier GmbH. All rights reserved.
« Previous
Next »
Phytomedicine
Volume 16, Issue 1
, Pages 56-64
, January 2009
